|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
14.14(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$202.16 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,827,736 |
2,490,136 |
3,605,616 |
3,694,042 |
Total Sell Value |
$734,360,254 |
$918,029,204 |
$1,190,266,600 |
$1,209,941,112 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
45 |
71 |
88 |
95 |
End Date |
2024-02-10 |
2023-11-09 |
2023-05-11 |
2022-05-11 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carley Brian T |
Director |
|
2024-02-20 |
4 |
OE |
$26.44 |
$364,396 |
D/D |
13,782 |
21,595 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-20 |
4 |
S |
$386.39 |
$5,404,823 |
D/D |
(13,988) |
5,525,959 |
|
-1% |
|
Troendle August J. |
CEO |
|
2024-02-20 |
4 |
S |
$386.39 |
$5,404,823 |
I/I |
(13,988) |
5,525,959 |
|
-1% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-16 |
4 |
S |
$391.75 |
$19,587,500 |
D/D |
(50,000) |
5,539,947 |
|
1% |
|
Troendle August J. |
CEO |
|
2024-02-16 |
4 |
S |
$391.75 |
$19,587,500 |
I/I |
(50,000) |
5,539,947 |
|
1% |
|
Mccarthy Cornelius P. Iii |
Director |
|
2024-02-08 |
4 |
OE |
$57.17 |
$269,271 |
D/D |
4,710 |
5,038 |
|
- |
|
Carley Brian T |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
103 |
7,813 |
|
- |
|
Kraft Robert O. |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
94 |
376 |
|
- |
|
Mccarthy Cornelius P. Iii |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
82 |
328 |
|
- |
|
Burwig Susan E |
Exec. VP, Operations |
|
2023-12-15 |
4 |
S |
$303.00 |
$608,727 |
D/D |
(2,009) |
15,283 |
|
-34% |
|
Burwig Susan E |
Exec. VP, Operations |
|
2023-12-14 |
4 |
S |
$304.15 |
$3,160,423 |
D/D |
(10,391) |
17,292 |
|
-33% |
|
Medpace Investors, Llc |
|
|
2023-12-01 |
4 |
S |
$273.26 |
$6,568,897 |
D/D |
(24,039) |
5,589,947 |
|
-43% |
|
Troendle August J. |
CEO |
|
2023-12-01 |
4 |
S |
$273.26 |
$6,568,897 |
I/I |
(24,039) |
5,589,947 |
|
-43% |
|
Medpace Investors, Llc |
|
|
2023-11-30 |
4 |
S |
$272.18 |
$2,142,329 |
D/D |
(7,871) |
5,613,986 |
|
-49% |
|
Troendle August J. |
CEO |
|
2023-11-30 |
4 |
S |
$272.18 |
$2,142,329 |
I/I |
(7,871) |
5,613,986 |
|
-49% |
|
Medpace Investors, Llc |
|
|
2023-11-29 |
4 |
S |
$272.62 |
$5,795,875 |
D/D |
(21,257) |
5,621,857 |
|
-46% |
|
Troendle August J. |
CEO |
|
2023-11-29 |
4 |
S |
$272.62 |
$5,795,875 |
I/I |
(21,257) |
5,621,857 |
|
-46% |
|
Troendle August J. |
CEO |
|
2023-11-28 |
4 |
S |
$273.66 |
$5,974,819 |
I/I |
(21,833) |
5,643,114 |
|
-50% |
|
Medpace Investors, Llc |
|
|
2023-11-28 |
4 |
S |
$273.66 |
$5,974,819 |
D/D |
(21,833) |
5,643,114 |
|
-50% |
|
Troendle August J. |
CEO |
|
2023-11-27 |
4 |
S |
$276.10 |
$6,902,500 |
I/I |
(25,000) |
5,664,947 |
|
-48% |
|
Medpace Investors, Llc |
|
|
2023-11-27 |
4 |
S |
$276.10 |
$6,902,500 |
D/D |
(25,000) |
5,664,947 |
|
-48% |
|
Troendle August J. |
CEO |
|
2023-11-22 |
4 |
S |
$277.81 |
$6,945,250 |
I/I |
(25,000) |
5,689,947 |
|
-41% |
|
Medpace Investors, Llc |
|
|
2023-11-22 |
4 |
S |
$277.81 |
$6,945,250 |
D/D |
(25,000) |
5,689,947 |
|
-41% |
|
Troendle August J. |
CEO |
|
2023-11-21 |
4 |
S |
$277.37 |
$6,934,250 |
I/I |
(25,000) |
5,714,947 |
|
-43% |
|
Medpace Investors, Llc |
|
|
2023-11-21 |
4 |
S |
$277.37 |
$6,934,250 |
D/D |
(25,000) |
5,714,947 |
|
-43% |
|
542 Records found
|
|
Page 3 of 22 |
|
|